A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.
Two abstracts on liquid biopsy tests revealed the potential of analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in promoting heightened decision-making by clinicians for ...
Hosted on MSN
Liquid biopsy blood test shows superior sensitivity in detecting HPV-associated head and neck cancers
A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...
IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its ...
Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space ...
Guardant Reveal™ is industry’s first blood-only test able to detect, with 7-day turnaround time, residual disease after surgery and recurrence months earlier than current standard-of-care methods ...
Please provide your email address to receive an email when new articles are posted on . Researchers at Johns Hopkins Sidney Kimmel Cancer Center have developed an automated liquid biopsy test that can ...
PALO ALTO, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s ...
New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results